Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P46098 (
5-HT3 receptor
)
2,290
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Homopentameric complexes of either the A or As subunit of the
5-hydroxytryptamine3 receptor
form Ca(2+)-permeable channels that can be activated by the selective agonist 1-(m-chlorophenyl)-biguanide (
mCPBG
). In both N1E-115 neuroblastoma cells and human embryonic kidney 293 cells stably expressing the
5-HT3 receptor
As subunit, (+)-verapamil, (-)-verapamil, diltiazem, and nimodipine caused reversible and concentration-dependent (IC50 = 2.5-6.5 microM) inhibition of the increases in cytosolic [Ca2+] evoked by
mCPBG
. In voltage-clamped human embryonic kidney 293 cells stably expressing the
5-HT3 receptor
As subunit, similar concentrations of the Ca2+ channel antagonists (IC50 = 3.0-6.8 microM) accelerated the rate at which 5-HT-evoked currents decayed without affecting the amplitude of the peak current. In equilibrium competition binding assays to membranes from Sf9 cells infected with the
5-HT3 receptor
As subunit, [3H]
mCPBG
and [3H]granisetron were displaced by (+)-verapamil, (-)-verapamil, and diltiazem; (+)-verapamil was approximately 10-fold more potent than (-)-verapamil and approximately-30-fold more potent than diltiazem. Nimodipine neither displaced [3H]granisetron binding nor affected its displacement by diltiazem and (+)-verapamil. The stereoselectivity of verapamil binding, which contrasts with the similar potency of each isomer in functional assays, was maintained when the incubations were performed at 20 degrees or when an antagonist of the
5-HT3 receptor
, [3H]granisetron, was used as the radioligand. The interaction between verapamil and either [3H]
mCPBG
or [3H]granisetron binding was not competitive. We conclude that the inhibition of [3H]
mCPBG
binding by diltiazem and verapamil is mediated by a site that is distinct from both the agonist-binding site and from the site through which nimodipine inhibits
5-HT3 receptor
function. Our results provide evidence for allosteric regulation of agonist binding to 5-HT3 receptors and the first example of a ligandgated ion channel whose function is directly inhibited by members of all three major classes of L-type Ca2+ channel antagonists.
...
PMID:Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels. 891 60
The present experiment examined changes in the ability of the selective
5-HT3 receptor
agonist, 1-(m-chlorophenyl)-biguanide (
mCPBG
), to facilitate K(+)-induced dopamine (DA) release during withdrawal from continuous cocaine administration. Rats were withdrawn from continuous cocaine administration (40 mg/kg per day cocaine for 14 days) for 7 days, and then slices from the nucleus accumbens obtained. Following an equilibration period, the slices were perfused with 0, 12.5, 25, or 50 microM
mCPBG
in the absence and presence of 25 mM K+. The samples were assayed for DA content by HPLC with electrochemical detection. Continuous cocaine administration significantly attenuated the ability of
mCPBG
to facilitate K(+)-induced DA overflow compared to saline control rats. These results suggest that continuous cocaine administration functionally down-regulates 5-HT3 receptors in the nucleus accumbens. These results further suggest that
5-HT3 receptor
subsensitivity may represent a partial mechanism for the tolerance induced by continuous cocaine administration.
...
PMID:5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine. 915 58
The effect of m-chlorophenylbiguanide, a selective
5-HT3 receptor
agonist, on gastric antral motility was investigated in conscious dogs with a force transducer implanted chronically.
m-Chlorophenylbiguanide
(0.1-1 mg/kg i.v.) dose dependently enhanced antral motility in the fasted state, and the amplitude of m-chlorophenylbiguanide (1 mg/kg i.v.)-induced antral contractions reached the level of natural phase III contractions. In contrast, m-chlorophenylbiguanide reduced the amplitude of antral contractions in the fed state. A selective
5-HT3 receptor
antagonist, ramosetron (0.0003-0.03 mg/kg i.v.), inhibited both effects of m-chlorophenylbiguanide.
m-Chlorophenylbiguanide
(1 mg/kg i.v.)-induced contractions were inhibited by atropine (0.03 or 0.1 mg/kg i.v.). These results indicate that pharmacological activation of 5-HT3 receptors has opposite effects on canine gastric antral motility in the fasted and in the fed state, being stimulatory and inhibitory, respectively. The stimulatory effect seems to be mediated mainly via the release of acetylcholine.
...
PMID:Effect of a selective 5-HT3 receptor agonist on gastric motility in fasted and fed dogs. 920 May 59
Efficacies of the 5-hydroxytryptamine (serotonin)
5-HT3 receptor
(
5-HT3R
) agonists 2-methyl-5-HT, dopamine, and m-chlorophenylbiguanide on
5-HT3R
native to N1E-115 cells and on homopentameric
5-HT3R
expressed in Xenopus oocytes were determined relative to that of 5-HT. Efficacies of 2-methyl-5-HT and dopamine on
5-HT3R
native to differentiated N1E-115 cells are high (54 and 36%) as compared with their efficacies on homopentameric
5-HT3R
-A(L) and
5-HT3R
-A(S) receptors expressed in oocytes (4-8%).
m-Chlorophenylbiguanide
does not distinguish between
5-HT3R
in N1E-115 cells and in oocytes. The distinct pharmacological profile of
5-HT3R
native to differentiated N1E-115 cells is conserved when poly(A)+ mRNA from these cells is expressed in oocytes. The results indicate that, apart from the known
5-HT3R
subunits, N1E-115 cells express additional proteins involved in
5-HT3R
function.
...
PMID:Native serotonin 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors. 928 59
We tested the antinociceptive effect of intrathecal (i.t.) administration of 5-HT3 and the
5-HT3 receptor
agonist, 1-(m-chlorophenyl)-biguanide (
mCPBG
), in rats submitted to a mechanical noxious stimulus and the influence of the
5-HT3 receptor
selective antagonists, tropisetron and granisetron. Both 5-HT and
mCPBG
(0.01, 0.1, 1, 10, 20 micrograms/rat) produced a significant dose-dependent antinociception. The lowest active doses were 0.1 and 1 microgram for 5-HT and
mCPBG
, respectively. The effect, observed with 20 micrograms, was significantly lower with
mCPBG
(+33 +/- 6%) than with 5-HT (+63 +/- 7%). For 5-HT-induced antinociception, the minimal inhibitory doses were 0.001 micrograms/rat for tropisetron and 10 micrograms/rat for granisetron. In contrast, the same doses of the two antagonists (from 0.1 microgram/rat) similarly inhibited the effect of
mCPBG
. This study provides evidence that contrary to tropisetron, doses of granisetron able to inhibit the effect of a
5-HT3 receptor
agonist failed to reduce that of 5-HT. This demonstrates a heterogeneity between
5-HT3 receptor
antagonists and questions the true involvement of these receptors in spinal 5-HT-induced antinociception.
...
PMID:Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats. 931 99
A complete understanding of how excitatory ligand-gated ion channels regulate intracellular Ca2+ in nerve cells remains to be elucidated. Laser-scanning confocal microscopy was used here to measure Ca2+ changes in the neuroblastoma x glioma hybrid cell line NG108-15, employed as a model nerve cell line, upon activation by the
5-HT3 receptor
, a serotonin-activated ligand-gated ion channel. Addition of the 5-HT3 agonist 1-m-(chlorophenyl)-biguanide (
mCPBG
) induced increases in [Ca2+]i in both the cytoplasm and the nuclei of the NG108-15 cells. Using high-time resolution line scanning, no delay was evident between the
mCPBG
-induced rise in cytosolic [Ca2+]i and the rise in nuclear [Ca2+]i. The agonist-induced responses were completely blocked by addition of EGTA to chelate external Ca2+ and by addition of the
5-HT3 receptor
antagonist tropisetron or the L-type Ca2+ channel blocker nitrendipine. Caffeine, but not thapsigargin, treatment significantly reduced the
mCPBG
-induced responses in the nucleus and the cytoplasm, both to the same extent. We conclude that, upon
5-HT3 receptor
activation, Ca2+ enters the cells through voltage-gated Ca2+ channels and then triggers the release of Ca2+ from ryanodine-sensitive intracellular stores, greatly amplifying the increases in Ca2+ in the cytoplasm and the nucleus.
...
PMID:5-HT3 receptors induce rises in cytosolic and nuclear calcium in NG108-15 cells via calcium-induced calcium release. 944 42
The
serotonin 5-HT3 receptor
, a ligand-gated ion channel, has previously been shown to be present on a subpopulation of brain nerve terminals, where, on activation, the 5-HT3 receptors induce Ca2+ influx. Whereas postsynaptic 5-HT3 receptors induce depolarization, being permeant to Na+ and K+, the basis of presynaptic
5-HT3 receptor
-induced calcium influx is unknown. Because the small size of isolated brain nerve terminals (synaptosomes) precludes electrophysiological measurements, confocal microscopic imaging has been used to detect calcium influx into them. Application of 100 nM 1-(m-chlorophenyl)biguanide (
mCPBG
), a highly specific
5-HT3 receptor
agonist, induced increases in internal free Ca2+ concentration ([Ca2+]i) and exocytosis in a subset of corpus striatal synaptosomes.
mCPBG
-induced increases in [Ca2+]i ranged from 1.3 to 1.6 times over basal values and were inhibited by 10 nM tropisetron, a potent and highly specific
5-HT3 receptor
antagonist, but were insensitive to the removal of external free Na+ (substituted with N-methyl-D-glucamine), to prior depolarization induced on addition of 20 mM K+, or to voltage-gated Ca2+ channel blockade by 10 microM Co2+/Cd2+ or by 1 microM omega-conotoxin MVIIC/1 microM oemga-conotoxin GVIA/200 nM agatoxin TK. In contrast, the Ca2+ influx induced by
5-HT3 receptor
activation in NG108-15 cells by 1 microM
mCPBG
was substantially reduced by 10 microM Co2+/Cd2+ and was completely blocked by 1 microM nitrendipine, an L-type Ca2+ channel blocker. We conclude that in contrast to the perikaryal 5-HT3 receptors, presynaptic 5-HT3 receptors appear to be uniquely calcium-permeant.
...
PMID:High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum. 948 30
Involvement of 5-hydroxytryptamine (5-HT)3 receptors in action of antidepressants was examined in the forced swim test in rats. Rats were forced to swim in a cylinder for 15 min on day 1 and for 5 min on day 2. Imipramine, desipramine and mianserin, administered after the 15-min swim session on day 1 and before the 5-min swim test on day 2, dose-dependently decreased the duration of immobility in the swim test on day 2. 1-(m-Chlorophenyl)-biguanide (
mCPBG
) attenuated the decreased duration of immobility induced by imipramine, desipramine and mianserin, although
mCPBG
did not affect the duration of immobility when it was given alone. ICS205-930 dose-dependently decreased the duration of immobility in the swim test on day 2, and the effect of ICS205-930 was attenuated by
mCPBG
. These results suggest that the suppression of
5-HT3 receptor
activity may contribute to the action of antidepressants.
...
PMID:The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats. 955 8
Several reports have indicated that the brain serotonergic 5-HT3 receptors are involved in at least some central effects of ethanol in rats. However, using an operant drug discrimination procedure, we have shown that these receptors are not primarily involved in the discriminative stimulus effects of ethanol. The aim of the present study was to further elucidate the role of 5-HT3 receptors in the formation of the ethanol-cueing effects in rats. To this purpose, a crossfamiliarization conditioned taste aversion (CF-CTA) procedure was used. Four daily injections of 1.5 g/kg ethanol (10% v/v) resulted in a significant attenuation of the subsequent ethanol-induced CTA. In contrast, four daily injections of the
5-HT3 receptor
agonist, 1-(m-chlorophenyl)-biguanide (
mCPBG
; 50 microg per rat, i.c.v.) did not alter the subsequent ethanol-induced CTA. The 50 microg dose of
mCPBG
produced a marked CTA in a control experiment. These results taken together with some previous findings from our laboratory suggest that the brain 5-HT3 receptors do not play any crucial role in the mediation of the discriminative stimulus effects of ethanol.
...
PMID:Prior repeated exposure to a 5-HT3 receptor agonist does not alter the ethanol-induced conditioned taste aversion in rats. 958 58
Serotonin (5-HT) receptor interaction in the control of female rat lordosis behavior was examined. Ovariectomized rats, with bilateral implants in the ventromedial nucleus of the hypothalamus (VMN), were hormonally primed with 25 micrograms estradiol benzoate and 500 micrograms progesterone. Rats were infused with the
5-HT3 receptor
antagonist, 3-tropanyl-indole-3 carbonylate (tropisetron; 500 ng), or were coinfused with the
5-HT3 receptor
antagonist and the 5-HT2A/2C receptor agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 500, 1500, or 2000 ng). Additional ovariectomized, hormone-primed rats received bilateral VMN infusions with the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT; 200 ng), or were coinfused with the 5-HT1A receptor agonist and the
5-HT3 receptor
agonist, m-chlorophenyl-biguanide (
mCPBG
; 250, 500, or 1000 ng). Lordosis behavior was observed prior to VMN infusion, during the infusion and for 30 consecutive minutes thereafter. Tropisetron reduced the lordosis to mount (L/M) ratio in every animal investigated but the decline was attenuated by coinfusion with DOI. Similarly, the L/M ratio declined following infusion with 8-OH-DPAT and the decline was dose-dependently reduced by coinfusion with
mCPBG
. Only the
5-HT3 receptor
agonist altered the quality of the lordosis reflex. These studies provide evidence that the effects of 5-HT on female rat lordosis behavior involve the integrated activity of at least 3 different 5-HT receptor families.
...
PMID:Functional integration among 5-hydroxytryptamine receptor families in the control of female rat sexual behavior. 974 22
<< Previous
1
2
3
4
Next >>